200P OlympiAD: Exploratory analysis of olaparib vs capecitabine in patients with germline BRCA-mutated (gBRCAm) metastatic breast cancer (mBC)
| Autor: | Robson, M., Delaloge, S., Domchek, S.M., Conte, P.F., Im, S-A., Xu, B., Armstrong, A., Masuda, N., Hettle, R., Fielding, A., Tung, N.M., Senkus-Konefka, E. |
|---|---|
| Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|